Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system.
Connecta Therapeutics has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in February 2024.
Connecta Therapeutics's investors include Inveready, ENISA, Centre for the Development of Industrial Technology (CDTI), Ministry of Science and Innovation of Spain, NextGenerationEU.
Connecta Therapeutics is headquartered in Barcelona, Spain.
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system.
Connecta Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Connecta Therapeutics — Funding & Investors." VCBacked, February 12, 2024, https://www.vcbacked.co/company/connecta-therapeutics. Accessed July 19, 2026.
VCBacked. (2024). Connecta Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/connecta-therapeutics
{{cite web |title=Connecta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/connecta-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated